Craniotomy with prosthetic heart valves: a clinical dilemma

References

• Bollag L, Attenhofer Jost C, Vogt P, et al. Symptomatic mechanical heart valve thrombosis: high morbidity and mortality despite successful treatment options. Swiss Med Wkly 2001; 131: 109–116
   PubMedGoogle Scholar
• Durrleman N, Pellerin M, Bouchard D, et al. Prosthetic valve thrombosis: twenty year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg 2004; 127: 1388–1392
   PubMed Web of Science ®Google Scholar
• Klugherz B, Herrmann H. Mechanical prosthetic valve thrombosis: case report and review of the literature. J Thromb Thrombolysis 1998; 6: 253–259
   PubMedGoogle Scholar
• Rupprecht T, Weil S, Winkler P, Kreuzer E, Pfister H. Successful cardiac surgery 24 hours after craniotomy in a patient with infective endocarditis and embolic cerebellar infarction: case report. J Heart Valve Dis 2004; 13: 228–230
   PubMedGoogle Scholar
• Jafri S. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3–15
   PubMed Web of Science ®Google Scholar
• Garcia D, Ageno W, Libby E, et al. Perioperative anticoagulation for patients with mechanical heart valves: a survey of current practice. J Thrombolysis 2004; 18(3)199–203
   PubMedGoogle Scholar
• Hering D, Piper C, Horstkotte D. Drug insight: an overview of current anticoagulation therapy after heart valve replacement. Nat Clin Pract Cardiovasc Med 2005; 2(8)415–422
   PubMedGoogle Scholar
• Bussey H. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves. J Heart Valve Dis 2004; 13(3)319–324
   PubMedGoogle Scholar
• Phillips S. Selecting the best heart valve for your patient: mechanical or tissue. Am Heart Hosp J 2004; 2(3)149–152
   PubMedGoogle Scholar
• Carrel T, Klingenmann W, Mohacsi P, Berdat P, Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis 1999; 8: 392–398
   PubMedGoogle Scholar
• Vink R, Kraaijenhagen R, Hutten B, et al. The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis. J Am Coll Cardiol 2003; 42: 2042–2048
   PubMed Web of Science ®Google Scholar
• Spyropoulos A, Turpie A. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Curr Opin Pulm Med 2005; 11(5)373–379
   PubMedGoogle Scholar
• Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000; 69: 264–265
   PubMed Web of Science ®Google Scholar
• Kearon C. Management of anticoagulation in patients who require invasive procedures. Semin Vasc Med 2003; 3: 285–294
   PubMedGoogle Scholar
• Brosnan C, Razis P. Complications of treatment: pulmonary embolism following craniotomy for meningioma. J Neurosurg Anesthesiol 1999; 11: 119–123
   PubMedGoogle Scholar
• Laohaprasit V, Mayberg M. Risks of anticoagulation therapy after experimental corticectomy in the rat. Neurosurgery 1993; 32: 625–628
   PubMedGoogle Scholar
• Schaible K, Smith L, Fessler R, Rachlin J, Brown F, Mullan S. Evaluation of the risks of anticoagulation therapy following experimental craniotomy in the rat. J Neurosurg 1985; 63: 959–962
   PubMedGoogle Scholar
• Norwood S, McAuley C, Berne J, et al. Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg 2002; 137: 696–701
   PubMed Web of Science ®Google Scholar
• Knovich M, Lesser G. The management of thromboembolic disease in patients with central nervous system malignancies. Curr Treat Options Oncol 2004; 5: 511–517
   PubMedGoogle Scholar
• Wijdicks E, Schievink W, Brown R, Mullany C. The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 1998; 42: 769–773
   PubMedGoogle Scholar